Literature DB >> 3361079

Thyroid carcinoma in thyrotoxic patients treated by surgery.

F Pacini1, R Elisei, G C Di Coscio, S Anelli, E Macchia, R Concetti, P Miccoli, M Arganini, A Pinchera.   

Abstract

We report the incidence of thyroid cancer in a series of 1832 consecutive patients seen for thyrotoxicosis of any etiology during 1970 and 1985 in our department. Surgical treatment for thyrotoxicosis was selected as the treatment of choice in 179 patients (9.8%), 86 with toxic diffuse goiter (TDG), 21 with toxic nodular goiter (TNG) and 40 with toxic adenoma (TA). The presence of thyroid cancer was found in 11 patients for a total incidence of 6.1%. Six patients had TDG (percent incidence in this group 6.9%), 4 patients had TNG (7.5%) and 1 had TA (2.5%). While the presence of thyroid cancer was totally unsuspected in TNG and TA, in TDG 4 out of 6 patients found to have a cancer, had been suspected before surgery. When a thyroid nodule was present in a toxic diffuse goiter the possibility to face with a malignant lesion reached 22.2% of the cases (4 out of 18 cases), while only 2 out of 68 patients (2.9%) with TDG and no nodule had thyroid cancer. These results confirm recent other series reporting the frequent association of hyperthyroidism and thyroid cancer and suggest that in thyrotoxic patients any nodule must be screened carefully to rule out malignancy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3361079     DOI: 10.1007/BF03350115

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period.

Authors:  L B WOOLNER; O H BEAHRS; B M BLACK; W M McCONAHEY; F R KEATING
Journal:  Am J Surg       Date:  1961-09       Impact factor: 2.565

2.  Incidence of carcinoma in thyroid glands removed at 1000 consecutive routine necropsies.

Authors:  J D MORTENSEN; W A BENNETT; L B WOOLNER
Journal:  Surg Forum       Date:  1955

3.  Incidence of malignancy in toxic and nontoxic nodular goiter.

Authors:  J E SOKAL
Journal:  J Am Med Assoc       Date:  1954-04-17

4.  Nodular goiter and malignant lesions of the thyroid gland.

Authors:  O H BEAHRS; J de J PEMBERTON; B M BLACK
Journal:  J Clin Endocrinol Metab       Date:  1951-10       Impact factor: 5.958

5.  Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study.

Authors:  B M Dobyns; G E Sheline; J B Workman; E A Tompkins; W M McConahey; D V Becker
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

6.  An autonomously functioning thyroid nodule, cancer, and prior radiation. Case report and hypothesis.

Authors:  D A Meier; J I Hamburger
Journal:  Arch Surg       Date:  1971-12

7.  Hyperthyroidism and thyroid cancer.

Authors:  E Olen; G H Klinck
Journal:  Arch Pathol       Date:  1966-06

8.  Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease.

Authors:  E Macchia; G F Fenzi; F Monzani; F Lippi; P Vitti; L Grasso; L Bartalena; L Baschieri; A Pinchera
Journal:  Clin Endocrinol (Oxf)       Date:  1981-08       Impact factor: 3.478

9.  Graves' disease and thyroid cancer.

Authors:  R Behar; M Arganini; T C Wu; M McCormick; F H Straus; L J DeGroot; E L Kaplan
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

10.  Thyroid stimulating antibodies and metastatic thyroid carcinoma.

Authors:  M H Snow; T Davies; B R Smith; W M Ross; R G Evans; C S Teng; R Hall
Journal:  Clin Endocrinol (Oxf)       Date:  1979-04       Impact factor: 3.478

View more
  22 in total

1.  Prevalence of incidental thyroid cancer and its ultrasonographic features in subcentimeter thyroid nodules of patients with hyperthyroidism.

Authors:  Dilek Berker; Serhat Isik; Ufuk Ozuguz; Yasemin Ates Tutuncu; Kerim Kucukler; Gulhan Akbaba; Yusuf Aydin; Serdar Guler
Journal:  Endocrine       Date:  2011-02       Impact factor: 3.633

2.  Thyroid cancer in hyperthyroidism: incidence rates and value of ultrasound-guided fine-needle aspiration biopsy in this patient group.

Authors:  M Sahin; N D Guvener; F Ozer; A Sengul; D Ertugrul; N B Tutuncu
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

3.  Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: an unusual clinical coexistence.

Authors:  G Mazziotti; M Rotondi; G Manganella; R Franco; V Colantuoni; G Amato; C Carella
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

4.  Cytopathological findings from fine-needle aspiration biopsy are accurate predictors of thyroid pathology in patients with functioning thyroid nodules.

Authors:  F Zelmanovitz; J L Gross
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

5.  Ultrasonographic features of papillary thyroid carcinoma in patients with Graves' disease.

Authors:  Jin Ook Chung; Dong Hyeok Cho; Dong Jin Chung; Min Young Chung
Journal:  Korean J Intern Med       Date:  2010-02-26       Impact factor: 2.884

6.  Thyroid cancer: current molecular perspectives.

Authors:  Francesca Giusti; Alberto Falchetti; Francesco Franceschelli; Francesca Marini; Annalisa Tanini; Maria Luisa Brandi
Journal:  J Oncol       Date:  2010-03-29       Impact factor: 4.375

7.  Thyroid carcinoma in Graves' disease.

Authors:  O Ozaki; K Ito; K Kobayashi; K Toshima; H Iwasaki; T Yashiro
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

8.  The outcome of patients with thyroid carcinoma and Graves' disease.

Authors:  Y Kasuga; A Sugenoya; S Kobayashi; H Masuda; F Iida
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

9.  Association of hyperfunctioning thyroid adenoma with thyroid cancer presenting as "trapping only" nodule at 99mTcO4- scintigraphy.

Authors:  L dell'Erba; P Gerundini; M Caputo; M Bagnasco
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

10.  Thyroid carcinoma after radioactive iodine therapy for Graves' disease.

Authors:  O Ozaki; K Ito; T Mimura; K Sugino; Y Kitamura; H Iwabuchi; M Kawano
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.